-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Provides Orphan Drug Designation To X4 Pharmaceuticals' Mavorixafor To Treat Congenital

Benzinga·08/26/2026 16:54:38
Listen to the news

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=919722